KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exact Sciences (EXAS) Convertible Debt (2018 - 2025)

Exact Sciences (EXAS) has disclosed Convertible Debt for 8 consecutive years, with $2.3 billion as the latest value for Q4 2025.

  • On a quarterly basis, Convertible Debt changed 0.26% to $2.3 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $2.3 billion, a 0.26% change, with the full-year FY2025 number at $2.3 billion, changed 0.26% from a year prior.
  • Convertible Debt was $2.3 billion for Q4 2025 at Exact Sciences, roughly flat from $2.3 billion in the prior quarter.
  • In the past five years, Convertible Debt ranged from a high of $2.3 billion in Q4 2025 to a low of $1.9 billion in Q1 2021.
  • A 5-year average of $2.2 billion and a median of $2.3 billion in 2023 define the central range for Convertible Debt.
  • Peak YoY movement for Convertible Debt: rose 23.03% in 2021, then fell 10.54% in 2024.
  • Exact Sciences' Convertible Debt stood at $2.2 billion in 2021, then rose by 0.27% to $2.2 billion in 2022, then rose by 5.86% to $2.3 billion in 2023, then grew by 0.29% to $2.3 billion in 2024, then grew by 0.26% to $2.3 billion in 2025.
  • Per Business Quant, the three most recent readings for EXAS's Convertible Debt are $2.3 billion (Q4 2025), $2.3 billion (Q3 2025), and $2.3 billion (Q2 2025).